| Barbara Kathleen Harvey, | |
|
4585 Sw 185th Ave, Aloha, OR 97078-1557 | |
| (503) 591-9280 | |
| Not Available |
| Full Name | Barbara Kathleen Harvey |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 4585 Sw 185th Ave, Aloha, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982168811 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Kathleen Harvey, 4585 Sw 185th Ave, Aloha, OR 97078-1557 Ph: () - | Barbara Kathleen Harvey, 4585 Sw 185th Ave, Aloha, OR 97078-1557 Ph: (503) 591-9280 |
News Archive
New findings led by Dr. Michael Lombardo, Prof. Simon Baron-Cohen and colleagues at the University of Cambridge indicate that testosterone levels early in fetal development influence later sensitivity of brain regions related to reward processing and affect an individual's susceptibility to engage in behavior, that in extremes, are related to several neuropsychiatric conditions that asymmetrically affect one sex more than the other.
The interaction of a ligand (Neurotrophine-3) and its dependence receptor (TrkC) constitutes a novel mechanism for tumor control in pediatric cancers such as neuroblastoma, and may also be important to the inhibition of other cancers such as breast cancer.
Santaris Pharma A/S, a privately-held biopharmaceutical company focused on developing RNA-based drugs targeted to disease-related mRNAs and microRNAs, today announced it has established operations in the United States. Internally and through its partners, the Company has a robust drug development pipeline including programs to treat metabolic disorders, infectious and inflammatory diseases, cancer and rare genetic disorders.
Chromoendoscopy is superior to random biopsy or white-light colonoscopy in detecting dysplasia in patients with inflammatory bowel diseases (IBD), according to a long-term surveillance study led by James F. Marion, MD, Professor of Medicine at Icahn School of Medicine at Mount Sinai, and Director of Education and Outreach at The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at The Mount Sinai Hospital, published online in the journal Clinical Gastroenterology and Hepatology.
› Verified 6 days ago
Kayla Olson, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4585 Sw 185th Ave, Aloha, OR 97078 Phone: 503-619-1935 | |
Lesley Dominic, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4585 Sw 185th Ave, Aloha, OR 97078 Phone: 503-591-9280 | |
Sarah Schwitkis, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4585 Sw 185th Ave, Aloha, OR 97078 Phone: 503-591-9280 Fax: 503-848-2072 | |
Barbara Anne Boyd, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4585 Sw 185th Ave, Aloha, OR 97078 Phone: 503-619-1949 | |
Zinaida Krivoruk, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4585 Sw 185th Ave, Aloha, OR 97078 Phone: 503-591-9280 | |
Mr. Matthew D Lauzon, MSW, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 4585 Sw 185th Ave, Aloha, OR 97007 Phone: 503-619-1559 Fax: 503-848-2072 | |
Eve Skosey-lalonde, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4585 Sw 185th Ave, Aloha, OR 97078 Phone: 503-591-9280 Fax: 503-848-2072 |